A Peninsula biotech company raised $68 million from investors — including a venture philanthropy fund started by Lululemon ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

The goal of genome editing technology is to develop strategies for the correction of those mutations that are responsible of ...

The Chinese scientist who was imprisoned for secretly creating the world’s first genetically-engineered babies has claimed he ...

The startup is using CRISPR tools to stop errant expression of a gene linked to facioscapulohumeral muscular dystrophy, a disorder on the radars of several drugmakers.

This study provides a potentially useful investigation into the positive role of BDNF/TrkB signaling in implanted dental pulp stem cells to enhance dentin regeneration in the context of dental caries.

CRISPR technique can target single genes essential for cancer cell survival, toppling the whole structure, says nanomedicine ...

Crispr Therapeutics said Chief Operating Officer Julianne Bruno would depart the company to pursue other opportunities, effective April 11. Bruno joined the gene-editing company in 2019 and stepped ...

CRISPR gene-editing technology offers curative potential for genetic diseases. The gene-editing market is projected to reach $30.8 billion by 2032. Top gene-editing pioneers include Intellia ...

Get Instant Summarized Text (Gist) An enhanced CRISPR tool, CRISPR-Cas12a, has been developed to enable simultaneous assessment of multiple genetic changes, improving disease modeling and gene editing ...

Focused on curing diseases like Alzheimer’s, Parkinson’s, and Huntington’s, Mammoth is advancing CRISPR beyond blood disorders to target the brain, muscle, and heart.